TrueBinding
truebinding.com
Biotechnology
Health Care
Neurology & CNS Therapeutics
Claim pageClaim
Follow
Overview
Connections
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$227.6M
4 rounds on record
Latest round
$57.7M
Venture round · Mar 2023 · 3 yr ago
Team
51-200
employees, estimated range
The money's age
Long since its last round
43 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 17, 2023
Raised a round Venture round $57.7M · SEC Form D
Sep 28, 2022
Raised a round Venture round $20.1M · SEC Form D
Nov 10, 2020
Raised a round Venture round $100M · SEC Form D
Oct 10, 2019
Raised a round Venture round $49.7M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2023 | $57.7M | — | SEC Form D |
| Venture round | Sep 2022 | $20.1M | — | SEC Form D |
| Venture round | Nov 2020 | $100M | — | SEC Form D |
| Venture round | Oct 2019 | $49.7M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | TrueBinding, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Dongxu SunExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Restoring energy. Next-generation disease-modifying medicines for ALS and Parkinson's.
What is Neurocarrus?Treating Neurodegenerative Disease and Pain Without Addiction.Neurocarrus is a biotech company developing a novel drug…
Accelerating the development of better drugs for better targets in a quest to alter the trajectory of neurodegenerative disease.
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly…
Visa sponsorship
0
H-1B filings in 12 months
1
Green card filings
$98k
Median offered salary
In the register as TrueBinding, Inc, Foster City, CA
Other sponsors in the same field
Alector 
Regeneron Pharmaceuticals 
IQVIA 
Daiichi Sankyo
Alert me
US Department of Labor · latest filing Mar 31, 2026 · Visa details by country
People
Dongxu Sun
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Foster City
United States
HQ
50-200 est. staff
300 Lincoln Centre Drive Foster City, CA, 94404 United States
Financials
Total raised
$227.6M
Latest round
Venture - Series Unknown
Funding rounds
4